Search Results - T. A. Lelyavina

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE by M. Yu. Sitnikova, T. A. Lelyavina, V. L. Galenko

    Published 2015-11-01

    Aim. To study trimetazidine (TZ) impact on the frequency of hospitalizations, structural and functional myocardium parameters, exercise tolerance (ET) in congestive heart failure patients (CHF) of nonischemic etiology (after myocarditis or DCMP), having complaints on chest pains.Material and methods...

    Full description

    Get full text
    Article
  2. 2

    Role of ergoreflex activity in the pathogenesis of heart failure. The effectiveness of physical rehabilitation by T. A. Lelyavina, M. Yu. Sitnikova, V. L. Galenko, M. A. Bortsova

    Published 2022-07-01

    Aim. To assess the change in ergoreflex activity in heart failure patients with reduced left ventricular systolic function in the study of the effectiveness of physical training (PT) with original regimen, compared with PT with conventionally estimated regimen.Material and methods. Single-center ope...

    Full description

    Get full text
    Article
  3. 3

    IMPORTANCE AND CORRECTNESS OF THE TERM “ANAEROBIC THRESHOLD”. THRESHOLD CHANGES OF COMPENSATORY AND ADAPTIVE BODY REACTIONS IN INCREASING PHYSICAL EXERTION by T. A. Lelyavina, M. Yu. Sitnikova, A. V. Berezina, E. V. Shlyakhto

    Published 2014-11-01

    A distinction of the physical exertion into phases is necessary for on-time decisionmaking of the correct clinical decisions in medicine and for evaluation of the level ofsportsmen professional preparedness in sport medicine.Aim. 1) To reveal the consequence of compensatory reactions in human bodydu...

    Full description

    Get full text
    Article
  4. 4

    PROGNOSTIC ROLE OF CHRONIC HEART FAILURE SEVERITY MARKERS AND RISK STRATIFICATION IN PATIENTS AGED 75 YEARS OR OLDER: BNUP-AGE SURVIVAL MODEL (NEVA-75) by M. Yu. Sitnikova, T. A. Lelyavina, E. V. Shlyakhto, V. V. Dorofeykov

    Published 2010-10-01

    To assess prognostic value of chronic heart failure (CHF) severity markers in patients aged over 74 years, and to optimise the risk stratification accordingly. This prospective study included 104 CHF patients aged 75 years or older, who were followed up for 2,5 years after hospital discharge. The ef...

    Full description

    Get full text
    Article
  5. 5

    The effect of aerobic exercise on muscle tissue in patients with severe heart failure and normal body weight by V. L. Galenko, T. A. Lelyavina, M. Yu. Sitnikova, G. Yu. Yukina, M. A. Bortsova, R. I. Dmitrieva

    Published 2020-07-01

    Aim. To assess the response of skeletal muscle and myocardium to original aerobic exercise (AE) program in patients with heart failure (HF) with reduced ejection fraction (HFrEF); to assess morphometric changes in skeletal muscle fiber after AE.Material and methods. The study included 100 patients w...

    Full description

    Get full text
    Article
  6. 6

    BK virus nephropathy in kidney transplantation (literature review by S. V. Popov, R. G. Huseynov, K. V. Sivak, I. N. Isakova-Sivak, V. V. Perepelitsa, T. A. Lelyavina

    Published 2024-09-01

    The article presents a review of the literature on the current problem of modern transplantology – BK viral nephropathy after nephrotransplantation. Risk factors for BK virus reactivation in immunocompromised patients are reflected. The issues of screening and diagnosis of BK viral infection in peop...

    Full description

    Get full text
    Article
  7. 7

    Adverse effects of immunosuppressive therapy after kidney transplant by S. V. Popov, R. G. Guseinov, K. V. Sivak, V. V. Perepelitsa, I. O. Schmidt, N. S. Bunenkov, T. A. Lelyavina

    Published 2025-03-01

    This paper reviews the sources and generality of knowledge regarding the adverse effects of immunosuppressive therapy, which play an important role in the full functioning of a transplant. The article regarding the importance of the dynamic impact of immunosuppressant medications on transplant funct...

    Full description

    Get full text
    Article
  8. 8

    Significant improvement of clinical course and reverse myocardial remodeling in young patients with chronic heart failure using cardiac contractility modulation by M. A. Vander, E. A. Lyasnikova, I. M. Kim, T. A. Lelyavina, M. Yu. Sitnikova, D. S. Lebedev, E. N. Mikhailov

    Published 2019-08-01

    Three clinical cases of 2-year follow-up of young patients with chronic heart failure with a low left ventricular ejection fraction of non-coronarogenic genesis after implantation of the cardiac contractility modulation system are presented. Significant positive dynamics of clinical course and rever...

    Full description

    Get full text
    Article
  9. 9

    Comparison of thulium and holmium lasers with conventional transurethral bladder resection for non-muscle invasive bladder cancer by S. V. Popov, R. G. Huseynov, E. V. Pomeshkin, O. N. Scriabin, K. V. Sivak, V. V. Perepelitsa, T. A. Lelyavina, E. A. Malyshev

    Published 2024-07-01

    Introduction. The gold standard of treatment for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) is transurethral resection of the bladder (TURB) in combination with intravesical therapy. However, this procedure may cause serious complications. At the same time, studies of var...

    Full description

    Get full text
    Article
  10. 10

    Management of heart failure patients in Russia: perspectives and realities of the second decade of the XXI century by E A Lyasnikova, P A Fedotov, M A Trukshina, V L Galenko, L V Prokopova, M A Simonenko, T A Lelyavina, M Yu Sitnikova

    Published 2021-10-01

    The article highlights the central components of Russian heart failure (HF) management programs in actual clinical practice. The experience of the Competence Center of Almazov National Medical Research Center, as well as opportunities and prospects for improving the monitoring of decompensated HF.

    Get full text
    Article
  11. 11

    Clinical case of recurrent aHUS after allogeneic cadaveric kidney transplantation by S. V. Popov, A. M. Esayan, R. G. Guseynov, I. N. Orlov, E. V. Lomonosova, V. V. Perepelitsa, О. A. Vorobyeva, A. V. Sadovnikova, T. A. Lelyavina

    Published 2024-01-01

    Introduction. Atypical hemolytic uremic syndrome (aHUS) is a systemic orphan disease that reproduces as an uncontrolled activation of the alternative pathway of the complement system and is expressed as systemic thrombotic microangiopathy (TMA). The classical triad of aHUS symptoms are hemolytic ane...

    Full description

    Get full text
    Article
  12. 12

    Choice Of treatment method for symptomatic Bladder outlet obstruction in patients with benign prostatic hyperplasia after kidney transplantation by S. V. Popov, R. G. Huseynov, D. A. Saydulaev, S. V. Sadovnikov, Yu. V. Kisil, K. V. Sivak, N. S. Bunenkov, V. V. Perepelitsa, A. S. Ulitina, T. A. Lelyavina

    Published 2023-07-01

    St. Petersburg, Russian Federation The paper presents a comparative assessment of different methods of treating symptomatic bladder outlet obstruction (BOO) in patients with benign prostatic hyperplasia (BPH) who underwent kidney transplantation (KT).

    Get full text
    Article
  13. 13

    The role of muscle tissue in the pathogenesis of chronic heart failure — the potential of exposure (FORMA study) by T. A. Lelyavina, M. Yu. Sitnikova, V. L. Galenko, P. S. Kozlov, M. A. Bortsova, E. A. Demchenko, O. S. Ganenko, A. S. Golovkin, A. A. Kostareva, R. I. Dmitrieva

    Published 2019-11-01

    Aim. To determine whether the skeletal muscle of patients with chronic heart failure (CHF) retains the ability to regenerate and grow; to compare the effectiveness of long aerobic trainings, calculated by an individualized method, and conventionally calculated trainings (VO2peak values), in relation...

    Full description

    Get full text
    Article
  14. 14

    Efficacy of extracorporeal shock wave lithotripsy for post-transplant kidney stones. Hope or Disappointment? by S. V. Popov, R. G. Huseynov, I. A. Miloserdov, Yu. V. Kisil, D. A. Saydulaev, S. V. Sadovnikov, K. V. Sivak, N. S. Bunenkov, V. V. Perepelitsa, T. A. Lelyavina

    Published 2023-09-01

    Nephrolithiasis in a transplanted kidney is an important medical and social problem. The presence of renal calculi may not manifest clinically for a long time due to the peculiarities of the surgical intervention during organ transplantation. Development of chronic urinary tract infection and deteri...

    Full description

    Get full text
    Article
  15. 15

    DYNAMIC OF PHYSICAL CAPACITY AND QUALITY OF LIFE AFTER HEART TRANSPLANTATION by M. A. Simonenko, A. V. Berezina, P. A. Fedotov, Y. V. Sazonova, T. M. Pervunina, T. A. Lelyavina, M. Y. Sitnikova, G. V. Nikolaev, M. L. Gordeev, M. A. Karpenko

    Published 2018-04-01

    Aim: to estimate physical capacity and quality of life (QoL) and defi ne factors which impact on their dynamic in recipients after heart transplantation (HTx).Materials and methods. From January 2010 to September 2016 we performed 76 HTx (mean age – 45,4 ± 1,6 yrs). Physical activity (PA) was evalua...

    Full description

    Get full text
    Article
  16. 16

    Transcriptome analysis of skeletal muscles revealed the effect of exercise on the molecular mechanisms regulating muscle growth and metabolism in patients with heart failure by O. A. Ivanova, E. V. Ignatieva, T. A. Lelyavina, V. L. Galenko, M. Yu. Komarova, M. A. Bortsova, M. Yu. Sitnikova, A. A. Kostareva, A. A. Sergushichev, R. I. Dmitrieva

    Published 2020-11-01

    Aim. Heart failure (HF) is accompanied by skeletal muscle atrophy and exercise intolerance. The aim was to study the molecular mechanisms underlying the therapeutic effect of personalized exercise in patients with HF.Material and methods. RNA sequencing obtained from skeletal muscle biopsies before...

    Full description

    Get full text
    Article
  17. 17

    Two-year follow-up of patients with heart failure with reduced ejection fraction receiving cardiac contractility modulation by M. A. Vander, E. A. Lyasnikova, L. A. Belyakova, M. A. Trukshina, V. L. Galenco, I. M. Kim, T. A. Lelyavina, M. Yu. Sitnikova, M. L. Abramov, D. S. Lebedev, E. N. Mikhaylov

    Published 2020-08-01

    Aim. To assess the 2-year prognosis of patients with heart failure with reduced ejection fraction (HFrEF) receiving cardiac contractility modulation (CCM).Material and methods. This single-center observational study included 55 patients (46 men, mean age 53±11 years) with NYHA class II-III HFrEF rec...

    Full description

    Get full text
    Article
  18. 18

    Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy by M. A. Vander, E. A. Lyasnikova, L. A. Belyakova, M. A. Trukshina, V. L. Galenko, I. M. Kim, T. A. Lelyavina, M. L. Abramov, T. A. Lyubimtseva, M. Yu. Sitnikova, D. S. Lebedev, E. N. Mikhaylov

    Published 2021-02-01

    Aim. To assess the clinical course and cardiac reverse remodeling in patients with heart failure (HF) with reduced ejection fraction (HFrEF) receiving cardiac contractility modulation (CCM) therapy.Material and methods. Fifty-five patients (mean age, 53±11 years, 46 males) with NYHA class II-III HFr...

    Full description

    Get full text
    Article